Epidemiology and predisposing factors of post-COVID venous thrombosis: a concise review
G Lippi, EJ Favaloro - Seminars in Thrombosis and Hemostasis, 2024 - thieme-connect.com
Long-coronavirus disease 2019 (COVID-19) represents a heterogeneous clinical syndrome
characterized by a pathologic continuum of signs, symptoms, and also laboratory/radiologic …
characterized by a pathologic continuum of signs, symptoms, and also laboratory/radiologic …
Risk factors for postdischarge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities: Insights from the CORE …
Background Coronavirus disease 2019 (COVID-19) is associated with venous and arterial
thromboembolism (VTE and ATE) and all-cause mortality (ACM) in hospitalized patients …
thromboembolism (VTE and ATE) and all-cause mortality (ACM) in hospitalized patients …
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE–COALITION VIII randomised clinical trial
Á Avezum, HAO Junior, PDMM Neves, LBO Alves… - …, 2023 - thelancet.com
Background COVID-19 progression is associated with an increased risk of arterial and
venous thrombosis. Randomised trials have demonstrated that anticoagulants reduce the …
venous thrombosis. Randomised trials have demonstrated that anticoagulants reduce the …
A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19
R Amani-Beni, M Kermani-Alghoraishi… - The Egyptian Heart …, 2023 - Springer
Background Coronavirus disease of 2019 (COVID-19) is associated with venous
thromboembolism (VTE), not only during hospitalization but also after discharge, raising …
thromboembolism (VTE), not only during hospitalization but also after discharge, raising …
Asymptomatic esophageal necrosis in a patient with recent COVID-19: The first case diagnosed through autopsy
Acute esophageal necrosis is a rare condition, characterized by a distinctive
endoscopic/necropsic image–circumferential black area of the esophagus. This paper …
endoscopic/necropsic image–circumferential black area of the esophagus. This paper …
[HTML][HTML] Prophylactic-dose direct oral anticoagulants for non-hospitalised people with COVID-19: A meta-analysis of randomised controlled trials
Q Song, H Liu, H Tan, B Yang, H Zhang… - Journal of Global …, 2024 - ncbi.nlm.nih.gov
Background Several reviews have been conducted on thromboprophylaxis in non-
hospitalised patients with coronavirus disease 2019 (COVID-19). In this systematic review …
hospitalised patients with coronavirus disease 2019 (COVID-19). In this systematic review …
[HTML][HTML] High-risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19
LB Kreuziger, T Kwon, RS Kasthuri, L Wahid… - Research and Practice …, 2024 - Elsevier
Abstract Background The Accelerating COVID-19 Therapeutic Interventions and Vaccines-
4c (ACTIV-4c) trial investigated prophylactic apixaban for 30 days following hospitalization …
4c (ACTIV-4c) trial investigated prophylactic apixaban for 30 days following hospitalization …
Pericardial and myocardial manifestations of COVID-19
S Savarimuthu, T Rajasekar, G Premkumar… - … -19's Consequences on …, 2024 - Elsevier
Abstract In January 2020 the World Health Organization declared a public health emergency
as reports of a virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
as reports of a virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
The thromboembolic effect of COVID-19
Currently available evidence suggests that coronavirus disease 2019 (COVID-19) cannot be
considered exclusively a respiratory disease, because the adverse effects of this viral …
considered exclusively a respiratory disease, because the adverse effects of this viral …